Hyperparathyroidism, Secondary - 21 Studies Found
| Completed |
: Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation : Secondary Hyperparathyroidism : 2010-04-19 :
|
| Completed |
: A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism : Secondary Hyperparathyroidism : 2012-07-25 : Drug: DP001 DP001 softgel capsules; 55 ng to 550 ng per dose, administered 3 times weekly for 4 weeks |
| Completed |
: Optimal Anemia Treatment in End Stage Renal Disease (ERSD) : Hyperparathyroidism, Secondary : 2014-06-27 :
|
| Terminated |
: Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism : Secondary Hyperparathyroidism : 2012-04-05 : Drug: Etelcalcetide Administered as an intravenous bolus three times a week at the end of each hemodialy |
| Completed |
: ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism : Secondary Hyperparathyroidism : 2005-08-24 :
|
| Completed |
: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. : Secondary Hyperparathyroidism Due to Renal Causes : 2013-08-28 :
|
| Completed |
: A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis :
: Drug: DP001 softgel capsules Other Names: |
| Terminated |
: Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects :
: 2008-04-21 :
|
| Terminated |
: Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism :
: |
| Terminated |
: Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis : Chronic Kidney Disease, Secondary Hyperparathyroidism : 2014-04-01 :
|